These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. SIDE-EFFECTS OF COMBINED RADIATION AND CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT TUMORS. OTTOMAN RE; LANGDON EA; ROCHLIN DB; SMART CR Radiology; 1963 Dec; 81():1014-7. PubMed ID: 14101708 [No Abstract] [Full Text] [Related]
24. FLUOROMETHOLONE (NSC-33001) AS A PALLIATIVE IN ADVANCED GASTROINTESTINAL CARCINOMA. MOERTEL CG; REITEMEIER RJ; HAHN RG; BLACKBURN CM Cancer Chemother Rep; 1964 Dec; 43():25-7. PubMed ID: 14250648 [No Abstract] [Full Text] [Related]
25. REGIONAL INTRA-ARTERIAL INFUSION OF 5-FLUOROURACIL FOR CANCER. HELSPER JT; DEMOSS EV Surgery; 1964 Aug; 56():340-8. PubMed ID: 14213829 [No Abstract] [Full Text] [Related]
26. THE TREATMENT OF CANCER BY ISOLATION PERFUSION. DONALDSON SS; FLETCHER WS Am J Nurs; 1964 Aug; 64():81-4. PubMed ID: 14180364 [No Abstract] [Full Text] [Related]
27. SOME PROBLEMS IN THE CHEMOTHERAPY OF SOLID TUMOURS. ARONOVITCH M; GROSZMAN M; KAHANA LM Can Med Assoc J; 1964 Mar; 90(11):678-84. PubMed ID: 14127380 [TBL] [Abstract][Full Text] [Related]
29. GASTROINTESTINAL BLEEDING AS A SEQUEL TO CANCER CHEMOTHERAPY. ROUSSELOT LM; COLE DR; GROSSI CE Am J Gastroenterol; 1965 Apr; 43():311-6. PubMed ID: 14280149 [No Abstract] [Full Text] [Related]
30. COMBINED SPLIT-COURSE THERAPY WITH 5-FLUOROURACIL AND MEGAVOLTAGE IRRADIATION. HOLSTI LR Ann Med Intern Fenn; 1964; 53():79-87. PubMed ID: 14233847 [No Abstract] [Full Text] [Related]
32. EVALUATION OF 5-FLUOROURACIL (5-FU) IN SURGICAL PRACTICE. GROESBECK HP; CUDMORE JT Am Surg; 1963 Oct; 29():683-91. PubMed ID: 14070785 [No Abstract] [Full Text] [Related]
33. EXPERIMENTAL AND CLINICAL USE OF FLUORINATED PYRIMIDINES IN CANCER CHEMOTHERAPY. HEIDELBERGER C; ANSFIELD FJ Cancer Res; 1963 Sep; 23():1226-43. PubMed ID: 14070379 [No Abstract] [Full Text] [Related]
34. INTRA-ARTERIAL CHEMOTHERAPY. LEVINE LA Am J Nurs; 1964 Mar; 64():108-10. PubMed ID: 14122024 [No Abstract] [Full Text] [Related]
35. FURTHER CLINICAL COMPARISON BETWEEN 5-FLUOROURACIL (5-FU) AND 5-FLUORO-2' -DEOXYURIDINE (5-FUDR). ANSFIELD FJ; CURRERI AR Cancer Chemother Rep; 1963 Oct; 32():101-5. PubMed ID: 14088828 [No Abstract] [Full Text] [Related]
36. CURRENT STATUS OF 5-FLUOROURACIL THERAPY IN FAR-ADVANCED NEOPLASTIC DISEASE. SCHELL HW Geriatrics; 1964 Apr; 19():265-70. PubMed ID: 14141804 [No Abstract] [Full Text] [Related]
37. REGIONAL PERFUSION CHEMOTHERAPY OF ADVANCED CANCER. LEONE LA R I Med J; 1963 Sep; 46():470-6. PubMed ID: 14048577 [No Abstract] [Full Text] [Related]
38. THE TREATMENT OF ADVANCED CANCER WITH A COMBINATION OF 5-FLUOROURACIL, CYTOXAN, AND METHOTREXATE. GRADY ED J Med Assoc Ga; 1964 Sep; 53():285-90. PubMed ID: 14246542 [No Abstract] [Full Text] [Related]
39. [ANTIMITOTIC CHEMOTHERAPY IN PATIENTS WITH MALIGNANT TUMORS, AS THE ONLY TREATMENT IN INOPERABLE CASES AND AS AN ASSOCIATION TO SURGICAL REMOVAL]. SFORZA M Arch Ital Patol Clin Tumori; 1964; 152():355-60. PubMed ID: 14268901 [No Abstract] [Full Text] [Related]
40. [5-FLUOROURACIL ALONE AND ASSOCIATED WITH RADIATION IN ONCOLOGY]. FIORENTINO M; CONTE G Tumori; 1963; 49():379-88. PubMed ID: 14148534 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]